Reports

Industry Research Reports

Global Atrial Septal Defect (ASD) Occluder Market Research Report 2026

Global Atrial Septal Defect (ASD) Occluder Market Research Report 2026

Industry: Medical Devices & Consumables

Published Date: 2026-04-17

Pages: 117 Pages

Report ld: 6473779

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global Atrial Septal Defect (ASD) Occluder market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Atrial Septal Defect (ASD) Occluder competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

The North American market for Atrial Septal Defect (ASD) Occluder is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Atrial Septal Defect (ASD) Occluder is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Atrial Septal Defect (ASD) Occluder include Gore Medical, Abbott, Lepu Medical, Lifetech, Occlutech, MicroPort Group, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Atrial Septal Defect (ASD) Occluder market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Atrial Septal Defect (ASD) Occluder. The Atrial Septal Defect (ASD) Occluder market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Atrial Septal Defect (ASD) Occluder market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Atrial Septal Defect (ASD) Occluder manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

  • Gore Medical
  • Abbott
  • Lepu Medical
  • Lifetech
  • Occlutech
  • MicroPort Group

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • 16-32 mm Type
  • 34-50 mm Type

Segment by Application

  • Children
  • Adult

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

marn_i1

Chapter 2: Provides a detailed analysis of the competitive landscape for Atrial Septal Defect (ASD) Occluder manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.

marn_i1

Chapter 3: Examines Atrial Septal Defect (ASD) Occluder sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.

marn_i1

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.

marn_i1

Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.

marn_i1

Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.

marn_i1

Chapter 7: Reviews the industry value chain, including upstream and downstream segments.

marn_i1

Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.

marn_i1

Chapter 9: Summarizes the key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Atrial Septal Defect (ASD) Occluder Market Overview

1.1 Product Definition

1.2 Atrial Septal Defect (ASD) Occluder by Type

1.2.1 Global Atrial Septal Defect (ASD) Occluder Market Value by Type: 2025 vs 2032

1.2.2 16-32 mm Type

1.2.3 34-50 mm Type

1.3 Atrial Septal Defect (ASD) Occluder by Application

1.3.1 Global Atrial Septal Defect (ASD) Occluder Market Value by Application: 2025 vs 2032

1.3.2 Children

1.3.3 Adult

1.4 Global Atrial Septal Defect (ASD) Occluder Market Size Estimates and Forecasts

1.4.1 Global Atrial Septal Defect (ASD) Occluder Revenue 2021–2032

1.4.2 Global Atrial Septal Defect (ASD) Occluder Sales 2021–2032

1.4.3 Global Atrial Septal Defect (ASD) Occluder Market Average Price (2021–2032)

1.5 Assumptions and Limitations

muLu

2 Atrial Septal Defect (ASD) Occluder Market Competition by Manufacturers

2.1 Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Manufacturers (2021–2026)

2.2 Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Atrial Septal Defect (ASD) Occluder Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Atrial Septal Defect (ASD) Occluder, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Atrial Septal Defect (ASD) Occluder, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Atrial Septal Defect (ASD) Occluder, Product Types and Applications

2.7 Global Key Manufacturers of Atrial Septal Defect (ASD) Occluder, Date of Entry into the Industry

2.8 Global Atrial Septal Defect (ASD) Occluder Market Competitive Situation and Trends

2.8.1 Global Atrial Septal Defect (ASD) Occluder Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Atrial Septal Defect (ASD) Occluder Players Market Share by Revenue

2.8.3 Global Atrial Septal Defect (ASD) Occluder Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

muLu

3 Global Atrial Septal Defect (ASD) Occluder Market Scenario by Region

3.1 Global Atrial Septal Defect (ASD) Occluder Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Atrial Septal Defect (ASD) Occluder Sales by Region: 2021–2032

3.2.1 Global Atrial Septal Defect (ASD) Occluder Sales by Region: 2021–2026

3.2.2 Global Atrial Septal Defect (ASD) Occluder Sales by Region: 2027–2032

3.3 Global Atrial Septal Defect (ASD) Occluder Revenue by Region: 2021–2032

3.3.1 Global Atrial Septal Defect (ASD) Occluder Revenue by Region: 2021–2026

3.3.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Region: 2027–2032

3.4 North America Atrial Septal Defect (ASD) Occluder Market Facts & Figures by Country

3.4.1 North America Atrial Septal Defect (ASD) Occluder Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Atrial Septal Defect (ASD) Occluder Sales by Country (2021–2032)

3.4.3 North America Atrial Septal Defect (ASD) Occluder Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Atrial Septal Defect (ASD) Occluder Market Facts & Figures by Country

3.5.1 Europe Atrial Septal Defect (ASD) Occluder Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Atrial Septal Defect (ASD) Occluder Sales by Country (2021–2032)

3.5.3 Europe Atrial Septal Defect (ASD) Occluder Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Atrial Septal Defect (ASD) Occluder Market Facts & Figures by Region

3.6.1 Asia Pacific Atrial Septal Defect (ASD) Occluder Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Atrial Septal Defect (ASD) Occluder Sales by Region (2021–2032)

3.6.3 Asia Pacific Atrial Septal Defect (ASD) Occluder Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Atrial Septal Defect (ASD) Occluder Market Facts & Figures by Country

3.7.1 Latin America Atrial Septal Defect (ASD) Occluder Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Atrial Septal Defect (ASD) Occluder Sales by Country (2021–2032)

3.7.3 Latin America Atrial Septal Defect (ASD) Occluder Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Atrial Septal Defect (ASD) Occluder Market Facts & Figures by Country

3.8.1 Middle East and Africa Atrial Septal Defect (ASD) Occluder Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Atrial Septal Defect (ASD) Occluder Sales by Country (2021–2032)

3.8.3 Middle East and Africa Atrial Septal Defect (ASD) Occluder Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

muLu

4 Segment by Type

4.1 Global Atrial Septal Defect (ASD) Occluder Sales by Type (2021–2032)

4.1.1 Global Atrial Septal Defect (ASD) Occluder Sales by Type (2021–2026)

4.1.2 Global Atrial Septal Defect (ASD) Occluder Sales by Type (2027–2032)

4.1.3 Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Type (2021–2032)

4.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Type (2021–2032)

4.2.1 Global Atrial Septal Defect (ASD) Occluder Revenue by Type (2021–2026)

4.2.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Type (2027–2032)

4.2.3 Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Type (2021–2032)

4.3 Global Atrial Septal Defect (ASD) Occluder Price by Type (2021–2032)

muLu

5 Segment by Application

5.1 Global Atrial Septal Defect (ASD) Occluder Sales by Application (2021–2032)

5.1.1 Global Atrial Septal Defect (ASD) Occluder Sales by Application (2021–2026)

5.1.2 Global Atrial Septal Defect (ASD) Occluder Sales by Application (2027–2032)

5.1.3 Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Application (2021–2032)

5.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Application (2021–2032)

5.2.1 Global Atrial Septal Defect (ASD) Occluder Revenue by Application (2021–2026)

5.2.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Application (2027–2032)

5.2.3 Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Application (2021–2032)

5.3 Global Atrial Septal Defect (ASD) Occluder Price by Application (2021–2032)

muLu

6 Key Companies Profiled

6.1 Gore Medical

6.1.1 Gore Medical Company Information

6.1.2 Gore Medical Description and Business Overview

6.1.3 Gore Medical Atrial Septal Defect (ASD) Occluder Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Gore Medical Atrial Septal Defect (ASD) Occluder Product Portfolio

6.1.5 Gore Medical Recent Developments/Updates

6.2 Abbott

6.2.1 Abbott Company Information

6.2.2 Abbott Description and Business Overview

6.2.3 Abbott Atrial Septal Defect (ASD) Occluder Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Abbott Atrial Septal Defect (ASD) Occluder Product Portfolio

6.2.5 Abbott Recent Developments/Updates

6.3 Lepu Medical

6.3.1 Lepu Medical Company Information

6.3.2 Lepu Medical Description and Business Overview

6.3.3 Lepu Medical Atrial Septal Defect (ASD) Occluder Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Lepu Medical Atrial Septal Defect (ASD) Occluder Product Portfolio

6.3.5 Lepu Medical Recent Developments/Updates

6.4 Lifetech

6.4.1 Lifetech Company Information

6.4.2 Lifetech Description and Business Overview

6.4.3 Lifetech Atrial Septal Defect (ASD) Occluder Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Lifetech Atrial Septal Defect (ASD) Occluder Product Portfolio

6.4.5 Lifetech Recent Developments/Updates

6.5 Occlutech

6.5.1 Occlutech Company Information

6.5.2 Occlutech Description and Business Overview

6.5.3 Occlutech Atrial Septal Defect (ASD) Occluder Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Occlutech Atrial Septal Defect (ASD) Occluder Product Portfolio

6.5.5 Occlutech Recent Developments/Updates

6.6 MicroPort Group

6.6.1 MicroPort Group Company Information

6.6.2 MicroPort Group Description and Business Overview

6.6.3 MicroPort Group Atrial Septal Defect (ASD) Occluder Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 MicroPort Group Atrial Septal Defect (ASD) Occluder Product Portfolio

6.6.5 MicroPort Group Recent Developments/Updates

muLu

7 Industry Chain and Sales Channels Analysis

7.1 Atrial Septal Defect (ASD) Occluder Industry Chain Analysis

7.2 Atrial Septal Defect (ASD) Occluder Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Atrial Septal Defect (ASD) Occluder Production Mode & Process Analysis

7.4 Atrial Septal Defect (ASD) Occluder Sales and Marketing

7.4.1 Atrial Septal Defect (ASD) Occluder Sales Channels

7.4.2 Atrial Septal Defect (ASD) Occluder Distributors

7.5 Atrial Septal Defect (ASD) Occluder Customer Analysis

muLu

8 Atrial Septal Defect (ASD) Occluder Market Dynamics

8.1 Atrial Septal Defect (ASD) Occluder Industry Trends

8.2 Atrial Septal Defect (ASD) Occluder Market Drivers

8.3 Atrial Septal Defect (ASD) Occluder Market Challenges

8.4 Atrial Septal Defect (ASD) Occluder Market Restraints

8.5 Impact of U.S. Tariffs

muLu

9 Research Findings and Conclusion

muLu

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Atrial Septal Defect (ASD) Occluder Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Atrial Septal Defect (ASD) Occluder Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Atrial Septal Defect (ASD) Occluder Market Competitive Situation by Manufacturers in 2025
Table 4. Global Atrial Septal Defect (ASD) Occluder Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Atrial Septal Defect (ASD) Occluder Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Atrial Septal Defect (ASD) Occluder Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Atrial Septal Defect (ASD) Occluder Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Atrial Septal Defect (ASD) Occluder, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Atrial Septal Defect (ASD) Occluder, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Atrial Septal Defect (ASD) Occluder, Product Types and Applications
Table 12. Global Key Manufacturers of Atrial Septal Defect (ASD) Occluder, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Atrial Septal Defect (ASD) Occluder Companies by Tier (Tier 1, Tier 2, Tier 3), based on Atrial Septal Defect (ASD) Occluder Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Atrial Septal Defect (ASD) Occluder Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Atrial Septal Defect (ASD) Occluder Sales by Region (K Units), 2021–2026
Table 18. Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Region (2021–2026)
Table 19. Global Atrial Septal Defect (ASD) Occluder Sales by Region (K Units), 2027–2032
Table 20. Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Region (2027–2032)
Table 21. Global Atrial Septal Defect (ASD) Occluder Revenue by Region (US$ Million), 2021–2026
Table 22. Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Region (2021–2026)
Table 23. Global Atrial Septal Defect (ASD) Occluder Revenue by Region (US$ Million), 2027–2032
Table 24. Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Region (2027–2032)
Table 25. North America Atrial Septal Defect (ASD) Occluder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Atrial Septal Defect (ASD) Occluder Sales by Country (K Units), 2021–2026
Table 27. North America Atrial Septal Defect (ASD) Occluder Sales by Country (K Units), 2027–2032
Table 28. North America Atrial Septal Defect (ASD) Occluder Revenue by Country (US$ Million), 2021–2026
Table 29. North America Atrial Septal Defect (ASD) Occluder Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Atrial Septal Defect (ASD) Occluder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Atrial Septal Defect (ASD) Occluder Sales by Country (K Units), 2021–2026
Table 32. Europe Atrial Septal Defect (ASD) Occluder Sales by Country (K Units), 2027–2032
Table 33. Europe Atrial Septal Defect (ASD) Occluder Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Atrial Septal Defect (ASD) Occluder Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Atrial Septal Defect (ASD) Occluder Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Atrial Septal Defect (ASD) Occluder Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Atrial Septal Defect (ASD) Occluder Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Atrial Septal Defect (ASD) Occluder Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Atrial Septal Defect (ASD) Occluder Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Atrial Septal Defect (ASD) Occluder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Atrial Septal Defect (ASD) Occluder Sales by Country (K Units), 2021–2026
Table 42. Latin America Atrial Septal Defect (ASD) Occluder Sales by Country (K Units), 2027–2032
Table 43. Latin America Atrial Septal Defect (ASD) Occluder Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Atrial Septal Defect (ASD) Occluder Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Atrial Septal Defect (ASD) Occluder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Atrial Septal Defect (ASD) Occluder Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Atrial Septal Defect (ASD) Occluder Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Atrial Septal Defect (ASD) Occluder Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Atrial Septal Defect (ASD) Occluder Revenue by Country (US$ Million), 2027–2032
Table 50. Global Atrial Septal Defect (ASD) Occluder Sales (K Units) by Type (2021–2026)
Table 51. Global Atrial Septal Defect (ASD) Occluder Sales (K Units) by Type (2027–2032)
Table 52. Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Type (2021–2026)
Table 53. Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Type (2027–2032)
Table 54. Global Atrial Septal Defect (ASD) Occluder Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Atrial Septal Defect (ASD) Occluder Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Type (2021–2026)
Table 57. Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Type (2027–2032)
Table 58. Global Atrial Septal Defect (ASD) Occluder Price (US$/Unit) by Type (2021–2026)
Table 59. Global Atrial Septal Defect (ASD) Occluder Price (US$/Unit) by Type (2027–2032)
Table 60. Global Atrial Septal Defect (ASD) Occluder Sales (K Units) by Application (2021–2026)
Table 61. Global Atrial Septal Defect (ASD) Occluder Sales (K Units) by Application (2027–2032)
Table 62. Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Application (2021–2026)
Table 63. Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Application (2027–2032)
Table 64. Global Atrial Septal Defect (ASD) Occluder Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Atrial Septal Defect (ASD) Occluder Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Application (2021–2026)
Table 67. Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Application (2027–2032)
Table 68. Global Atrial Septal Defect (ASD) Occluder Price (US$/Unit) by Application (2021–2026)
Table 69. Global Atrial Septal Defect (ASD) Occluder Price (US$/Unit) by Application (2027–2032)
Table 70. Gore Medical Company Information
Table 71. Gore Medical Description and Business Overview
Table 72. Gore Medical Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Gore Medical Atrial Septal Defect (ASD) Occluder Product
Table 74. Gore Medical Recent Developments/Updates
Table 75. Abbott Company Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Abbott Atrial Septal Defect (ASD) Occluder Product
Table 79. Abbott Recent Developments/Updates
Table 80. Lepu Medical Company Information
Table 81. Lepu Medical Description and Business Overview
Table 82. Lepu Medical Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Lepu Medical Atrial Septal Defect (ASD) Occluder Product
Table 84. Lepu Medical Recent Developments/Updates
Table 85. Lifetech Company Information
Table 86. Lifetech Description and Business Overview
Table 87. Lifetech Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Lifetech Atrial Septal Defect (ASD) Occluder Product
Table 89. Lifetech Recent Developments/Updates
Table 90. Occlutech Company Information
Table 91. Occlutech Description and Business Overview
Table 92. Occlutech Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Occlutech Atrial Septal Defect (ASD) Occluder Product
Table 94. Occlutech Recent Developments/Updates
Table 95. MicroPort Group Company Information
Table 96. MicroPort Group Description and Business Overview
Table 97. MicroPort Group Atrial Septal Defect (ASD) Occluder Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. MicroPort Group Atrial Septal Defect (ASD) Occluder Product
Table 99. MicroPort Group Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Atrial Septal Defect (ASD) Occluder Distributors List
Table 103. Atrial Septal Defect (ASD) Occluder Customers List
Table 104. Atrial Septal Defect (ASD) Occluder Market Trends
Table 105. Atrial Septal Defect (ASD) Occluder Market Drivers
Table 106. Atrial Septal Defect (ASD) Occluder Market Challenges
Table 107. Atrial Septal Defect (ASD) Occluder Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
muLu

List of Figures

Figure 1. Product Picture of Atrial Septal Defect (ASD) Occluder
Figure 2. Global Atrial Septal Defect (ASD) Occluder Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Atrial Septal Defect (ASD) Occluder Market Share by Type: 2025 & 2032
Figure 4. 16-32 mm Type Product Picture
Figure 5. 34-50 mm Type Product Picture
Figure 6. Global Atrial Septal Defect (ASD) Occluder Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Atrial Septal Defect (ASD) Occluder Market Share by Application: 2025 & 2032
Figure 8. Children
Figure 9. Adult
Figure 10. Global Atrial Septal Defect (ASD) Occluder Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Atrial Septal Defect (ASD) Occluder Market Size (US$ Million), 2021–2032
Figure 12. Global Atrial Septal Defect (ASD) Occluder Sales (K Units), 2021–2032
Figure 13. Global Atrial Septal Defect (ASD) Occluder Average Price (US$/Unit), 2021–2032
Figure 14. Atrial Septal Defect (ASD) Occluder Report Years Considered
Figure 15. Atrial Septal Defect (ASD) Occluder Sales Share by Manufacturers in 2025
Figure 16. Global Atrial Septal Defect (ASD) Occluder Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Atrial Septal Defect (ASD) Occluder Players: Market Share by Revenue in Atrial Septal Defect (ASD) Occluder in 2025
Figure 18. Atrial Septal Defect (ASD) Occluder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Atrial Septal Defect (ASD) Occluder Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Atrial Septal Defect (ASD) Occluder Sales Market Share by Country (2021–2032)
Figure 21. North America Atrial Septal Defect (ASD) Occluder Revenue Market Share by Country (2021–2032)
Figure 22. United States Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Atrial Septal Defect (ASD) Occluder Sales Market Share by Country (2021–2032)
Figure 25. Europe Atrial Septal Defect (ASD) Occluder Revenue Market Share by Country (2021–2032)
Figure 26. Germany Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Atrial Septal Defect (ASD) Occluder Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Atrial Septal Defect (ASD) Occluder Revenue Market Share by Region (2021–2032)
Figure 33. China Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Indonesia Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Thailand Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Malaysia Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Atrial Septal Defect (ASD) Occluder Sales Market Share by Country (2021–2032)
Figure 43. Latin America Atrial Septal Defect (ASD) Occluder Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Atrial Septal Defect (ASD) Occluder Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Atrial Septal Defect (ASD) Occluder Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Atrial Septal Defect (ASD) Occluder Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Atrial Septal Defect (ASD) Occluder by Type (2021–2032)
Figure 53. Global Revenue Market Share of Atrial Septal Defect (ASD) Occluder by Type (2021–2032)
Figure 54. Global Atrial Septal Defect (ASD) Occluder Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Atrial Septal Defect (ASD) Occluder by Application (2021–2032)
Figure 56. Global Revenue Market Share of Atrial Septal Defect (ASD) Occluder by Application (2021–2032)
Figure 57. Global Atrial Septal Defect (ASD) Occluder Price (US$/Unit) by Application (2021–2032)
Figure 58. Atrial Septal Defect (ASD) Occluder Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Atrial Septal Defect (ASD) Occluder market?zhanKai
The top companies in the global Atrial Septal Defect (ASD) Occluder market are Gore Medical、Abbott、Lepu Medical.
den_biaoTiZhungShi

Related Reports

Global Atrial Septal Defect (ASD) Occluder Market Research Report 2026

Industry: Medical Devices & Consumables

Published Date: 2026-04-17

Pages: 117 Pages

Report ld: 6473779

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now